Abstract
Biofilms play an important role in many chronic infectious diseases of the ear, nose, and throat (ENT), including rhino-sinusitis, otitis media with effusion, cholesteatoma, and chronic adenotonsillitis, as well as infections associated with implants and prostheses. As a consequence of an increased use of implants and prostheses in ENT patients, there has been an increased incidence of infections and associated biofilms. Common strategies behind the treatment of biofilms include antimicrobial neutralization, the dispersion of existing biofilms, and the disruption of quorum sensing. Prevention is the most efficient way of combating biofilms, achieved by aseptic precaution, ultraclean operating theaters, sterilization of surgical instruments and implants, and the use of prophylactic antibiotics and antibiotic-coated implants. There is still a significant lack of knowledge about the stages of biofilm formation, making its management more challenging. Ear, nose, and throat surgeons need to understand the role of biofilms and be aware of methods of treatment and prevention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Babb JR, Lynam P, Ayliffe GA (1995) Risk of airborne transmission in an operating theatre containing four ultraclean air units. J Hosp Infect 31(3):159–68
Brady AJ, Farnan TB, Toner JG, Gilpin DF, Tunney MM (2010) Treatment of a cochlear implant biofilm infection: a potential role for alternative antimicrobial agents. J Laryngol Otol 124(7):729–738. https://doi.org/10.1017/S0022215110000319
Camps J, Pujol I, Ballester F, Joven J, Simó JM (2011) Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteria. Antimicrob Agents Chemother 55(4):1325–1331. https://doi.org/10.1128/aac.01502-10
Chen H-H, Liu X, Ni C, Lu Y-P, Xiong G-Y, Lu Y-Y et al (2012) Bacterial biofilms in chronic rhinosinusitis and their relationship with inflammation severity. Auris Nasus Larynx, 39(2):169–74. https://doi.org/10.1016/j.anl.2011.04.014
Chow TT, Yang XY (2004) Ventilation performance in operating theatres against airborne infection: review of research activities and practical guidance. J Hosp Infect 56(2):85–92. https://doi.org/10.1016/j.jhin.2003.09.020
Coticchia J, Zuliani G, Coleman C, Carron M, Gurrola J, Haupert M et al (2007) Biofilm surface area in the pediatric nasopharynx: chronic rhinosinusitis vs obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 133(2):110–114. https://doi.org/10.1001/archotol.133.2.110
Donelli G, Francolini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C et al (2007) Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 51(8):2733–2740. https://doi.org/10.1128/aac.01249-06
Fastenberg JH, Hsueh WD, Mustafa A, Akbar NA, Abuzeid WM (2016) Biofilms in chronic rhinosinusitis: pathophysiology and therapeutic strategies. World J Otorhinolaryngol Head Neck Surg 2(4):219–229. https://doi.org/10.1016/j.wjorl.2016.03.002
Hall-Stoodley L, Stoodley P, Kathju S, Høiby N, Moser C, Costerton JW et al (2006) Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296(2):202–211. https://doi.org/10.1001/jama.296.2.202
Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35(4):322–332. https://doi.org/10.1016/j.ijantimicag.2009.12.011
Im GJ, An YS, Choi J, Song JJ, Chae SW, Jung HH (2015) Analysis of bacterial biofilms on a cochlear implant following methicillin-resistant Staphylococcus aureus infection. Korean J Audiol 19(3):172–177. https://doi.org/10.7874/jao.2015.19.3.172
Kania RE, Lamers GEM, Vonk MJ, Huy PTB, Hiemstra PS, Bloemberg G V et al (2007) Demonstration of bacterial cells and glycocalyx in biofilms on human tonsils. Arch Otolaryngol Head Neck Surg 133(2):115–121. https://doi.org/10.1001/archotol.133.2.115
Macassey E, Dawes P (2008) Biofilms and their role in otorhinolaryngological disease. J Laryngol Otol 122(12):1273–1278. https://doi.org/10.1017/S0022215108002193
Malaty J, Antonelli PJ (2008) Effect of blood and mucus on tympanostomy tube biofilm formation. Laryngoscope 118(5):867–870. https://doi.org/10.1097/mlg.0b013e3181671b02
Marcuzzo AV, Tofanelli M, Boscolo Nata F, Gatto A, Tirelli G (2017) Hyaluronate effect on bacterial biofilm in ENT district infections: a review. Apmis 125(9):763–772. https://doi.org/10.1111/apm.12728
Mena Viveros N (2014) Biofilms en otorrinolaringologÃa. Acta Otorrinolaringol Esp 65(1):47–52. https://doi.org/10.1016/j.otorri.2012.08.005
Post JC, Hiller NL, Nistico L, Stoodley P, Ehrlich GD (2007) The role of biofilms in otolaryngologic infections: update 2007. Curr Opin Otolaryngol Head Neck Surg 15(5):347–351. https://doi.org/10.1097/moo.0b013e3282b97327
Smith A, Buchinsky FJ, Post JC (2011) Eradicating chronic ear, nose, and throat infections: a systematically conducted literature review of advances in biofilm treatment. Otolaryngol Head Neck Surg 144(3):338–347. https://doi.org/10.1177/0194599810391620
Zuliani G, Carron M, Gurrola J, Coleman C, Haupert M, Berk R et al (2006) Identification of adenoid biofilms in chronic rhinosinusitis. Int J Pediatr Otorhinolaryngol 70(9):1613–1617. https://doi.org/10.1016/j.ijporl.2006.05.002
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ravi Sankar, M., Arulalan, M., Keshri, A.K. (2019). Biofilm-Mediated Diseases of the Ear, Nose, and Throat (ENT). In: Kumar, S., Chandra, N., Singh, L., Hashmi, M., Varma, A. (eds) Biofilms in Human Diseases: Treatment and Control. Springer, Cham. https://doi.org/10.1007/978-3-030-30757-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-30757-8_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30756-1
Online ISBN: 978-3-030-30757-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)